De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Changchun High-Tech Industry (Group) Toekomstige groei
Future criteriumcontroles 1/6
Changchun High-Tech Industry (Group) zal naar verwachting groeien in winst en omzet met respectievelijk 15% en 10.5% per jaar. De winst per aandeel zal naar verwachting groeien met 14.6% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 16.4% zijn.
Belangrijke informatie
15.0%
Groei van de winst
14.6%
Groei van de winst per aandeel
| Pharmaceuticals winstgroei | 18.5% |
| Inkomstengroei | 10.5% |
| Toekomstig rendement op eigen vermogen | 16.4% |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 20 Aug 2024 |
Recente toekomstige groei-updates
Changchun High-Tech Industry (Group) Co., Ltd. Just Missed Revenue By 11%: Here's What Analysts Think Will Happen Next
Aug 18
Changchun High-Tech Industry (Group) Co., Ltd. (SZSE:000661) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Apr 23Earnings Miss: Changchun High-Tech Industries (Group) Inc. Missed EPS By 6.6% And Analysts Are Revising Their Forecasts
Mar 22Recent updates
Changchun High-Tech Industry (Group) Co., Ltd.'s (SZSE:000661) Share Price Boosted 33% But Its Business Prospects Need A Lift Too
Sep 30Here's Why Changchun High-Tech Industry (Group) (SZSE:000661) Can Manage Its Debt Responsibly
Sep 29Changchun High-Tech Industry (Group) Co., Ltd. Just Missed Revenue By 11%: Here's What Analysts Think Will Happen Next
Aug 18Improved Earnings Required Before Changchun High-Tech Industry (Group) Co., Ltd. (SZSE:000661) Shares Find Their Feet
Aug 15Changchun High-Tech Industry (Group) (SZSE:000661) Seems To Use Debt Rather Sparingly
Jun 12Changchun High-Tech Industry (Group) Co., Ltd. (SZSE:000661) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Apr 23Benign Growth For Changchun High-Tech Industries (Group) Inc. (SZSE:000661) Underpins Its Share Price
Apr 12Earnings Miss: Changchun High-Tech Industries (Group) Inc. Missed EPS By 6.6% And Analysts Are Revising Their Forecasts
Mar 22Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 19,267 | 5,792 | N/A | 6,125 | 9 |
| 12/31/2025 | 17,748 | 5,342 | N/A | 5,432 | 9 |
| 12/31/2024 | 15,261 | 4,081 | N/A | 4,738 | 4 |
| 6/30/2024 | 15,037 | 4,092 | 2,852 | 5,058 | N/A |
| 3/31/2024 | 14,966 | 4,534 | 3,148 | 5,303 | N/A |
| 12/31/2023 | 14,566 | 4,532 | 3,007 | 5,104 | N/A |
| 9/30/2023 | 13,663 | 4,288 | 2,745 | 4,852 | N/A |
| 6/30/2023 | 12,964 | 4,181 | 1,643 | 3,937 | N/A |
| 3/31/2023 | 12,430 | 3,859 | 981 | 3,160 | N/A |
| 1/1/2023 | 12,627 | 4,141 | 735 | 2,826 | N/A |
| 9/30/2022 | 12,154 | 4,075 | 1,173 | 3,197 | N/A |
| 6/30/2022 | 11,615 | 3,954 | 965 | 2,937 | N/A |
| 3/31/2022 | 11,440 | 4,021 | 1,097 | 3,319 | N/A |
| 1/1/2022 | 10,747 | 3,757 | 1,101 | 3,331 | N/A |
| 9/30/2021 | 10,416 | 3,934 | -768 | 1,158 | N/A |
| 6/30/2021 | 9,623 | 3,660 | -26 | 1,603 | N/A |
| 3/31/2021 | 9,197 | 3,379 | 109 | 1,389 | N/A |
| 12/31/2020 | 8,577 | 3,047 | 14 | 1,111 | N/A |
| 9/30/2020 | 8,329 | 2,795 | 1,050 | 2,043 | N/A |
| 6/30/2020 | 7,899 | 2,358 | 1,064 | 1,899 | N/A |
| 3/31/2020 | 7,260 | 1,952 | 741 | 1,654 | N/A |
| 12/31/2019 | 7,374 | 1,775 | 1,090 | 1,935 | N/A |
| 9/30/2019 | 6,679 | 1,408 | 1,350 | 2,159 | N/A |
| 6/30/2019 | 6,017 | 1,185 | 670 | 1,547 | N/A |
| 3/31/2019 | 6,118 | 1,161 | 947 | 1,710 | N/A |
| 12/31/2018 | 5,375 | 1,006 | 198 | 884 | N/A |
| 9/30/2018 | 5,594 | 1,014 | 124 | 614 | N/A |
| 6/30/2018 | 5,251 | 926 | 454 | 809 | N/A |
| 3/31/2018 | 4,393 | 728 | N/A | 175 | N/A |
| 12/31/2017 | 4,102 | 662 | N/A | 381 | N/A |
| 9/30/2017 | 3,353 | 592 | N/A | 256 | N/A |
| 6/30/2017 | 3,222 | 554 | N/A | 184 | N/A |
| 3/31/2017 | 2,995 | 506 | N/A | 396 | N/A |
| 12/31/2016 | 2,897 | 485 | N/A | 308 | N/A |
| 9/30/2016 | 2,877 | 467 | N/A | 351 | N/A |
| 6/30/2016 | 2,603 | 423 | N/A | 327 | N/A |
| 3/31/2016 | 2,526 | 411 | N/A | 627 | N/A |
| 12/31/2015 | 2,402 | 384 | N/A | 771 | N/A |
| 9/30/2015 | 2,623 | 446 | N/A | 699 | N/A |
| 6/30/2015 | 2,460 | 388 | N/A | 423 | N/A |
| 3/31/2015 | 2,336 | 349 | N/A | 267 | N/A |
| 12/31/2014 | 2,262 | 318 | N/A | 280 | N/A |
| 9/30/2014 | 1,921 | 250 | N/A | 283 | N/A |
| 6/30/2014 | 1,960 | 240 | N/A | 496 | N/A |
| 3/31/2014 | 2,005 | 279 | N/A | 553 | N/A |
| 12/31/2013 | 2,049 | 284 | N/A | 499 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei 000661 ( 15% per jaar) ligt boven de spaarquote ( 2.9% ).
Winst versus markt: De winst van 000661 ( 15% per jaar) zal naar verwachting langzamer groeien dan de markt CN ( 23.2% per jaar).
Hoge groeiwinsten: De winst van 000661 zal naar verwachting groeien, maar niet aanzienlijk.
Omzet versus markt: De omzet van 000661 ( 10.5% per jaar) zal naar verwachting langzamer groeien dan de markt CN ( 13.2% per jaar).
Hoge groei-inkomsten: De omzet van 000661 ( 10.5% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen 000661 zal naar verwachting over 3 jaar laag zijn ( 16.4 %).